Page last updated: 2024-08-16

phenylephrine and pyruvaldehyde

phenylephrine has been researched along with pyruvaldehyde in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cosentino, F; Costantino, S; Paneni, F	1

Other Studies

1 other study(ies) available for phenylephrine and pyruvaldehyde

Article	Year
p66(Shc)-induced redox changes drive endothelial insulin resistance. Atherosclerosis, 2014, Volume: 236, Issue:2 Topics: Animals; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Fatty Acids, Nonesterified; Insulin; Insulin Resistance; Intramolecular Oxidoreductases; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Molecular Targeted Therapy; NF-kappa B; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Phenylephrine; Pyruvaldehyde; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Superoxides; Vasodilation	2014

Article

Year

p66(Shc)-induced redox changes drive endothelial insulin resistance.

Atherosclerosis, 2014, Volume: 236, Issue:2

Topics: Animals; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Fatty Acids, Nonesterified; Insulin; Insulin Resistance; Intramolecular Oxidoreductases; Leptin; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Obese; Molecular Targeted Therapy; NF-kappa B; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Phenylephrine; Pyruvaldehyde; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Shc Signaling Adaptor Proteins; Src Homology 2 Domain-Containing, Transforming Protein 1; Superoxides; Vasodilation

2014